Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery process is fraught with risk but also tremendous possibilities.
That means an investor needs an iron will to enter the market. Don’t go in expecting overnight riches, because the road to drug approval is long and arduous. Along the way will be many hills and valleys that can easily shake a veteran biotech investor.
Yet because of the promise biotech stocks bring to the market, it is an exciting one nonetheless and the following two biotechs are some of the best to consider buying before the end of the month.
This post originally appeared at 24/7 Wall St.